@article{25a8f83ffe6943dfbfb5d6b6dc547ae6,
title = "Interrogating the Tumor Microenvironment and Molecular Targets of Immunotherapy: A New Opportunity for Multimodality Imaging",
author = "Pagel, {Mark D.}",
note = "Funding Information: Disclosures of conflicts of interest: M.D.P. NIH grants R01 CA231513, R43 CA265603, and R01 CA269354 (not related to this manuscript); honoraria and travel support for scientific presentations at Stanford University, NC State University, Indian Institute of Science, Texas A&M University, University of Wisconsin, Washington University in St Louis, Wayne State University, Stony Brook University, University of Pennsylvania, UT Southwestern Medical Center, the University of Chicago, the TERMIS meeting, the Contrast Media Research Conference, and the Annual CEST MRI Workshop (not related to this manuscript); Fellow, World Molecular Imaging Society; Organizing Committee, Imaging in 2020 meeting (not related to this manuscript); receipt of equipment or materials from O2M Technologies, NIRvana Sciences, Roche Pharma, Nanology Labs, pHLIP Inc, PhotoSound, and GE Healthcare (not related to this manuscript).",
year = "2023",
month = jul,
doi = "10.1148/rycan.230098",
language = "English (US)",
volume = "5",
journal = "Radiology: Imaging Cancer",
issn = "2638-616X",
publisher = "Radiological Society of North America Inc.",
number = "4",
}